RA Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,155,964
| Closed | -$29M | – | 110 |
|
|
2022
Q1 | $29M | Buy |
+1,155,964
| New | +$29M | 0.63% | 46 |
|
|
2021
Q4 | – | Sell |
-218,532
| Closed | -$3.74M | – | 105 |
|
|
2021
Q3 | $3.74M | Sell |
218,532
-3,278,107
| -94% | -$56.1M | 0.05% | 92 |
|
|
2021
Q2 | $46.8M | Sell |
3,496,639
-60,171
| -2% | -$806K | 0.75% | 43 |
|
|
2021
Q1 | $182M | Sell |
3,556,810
-1,219,738
| -26% | -$62.5M | 2.75% | 8 |
|
|
2020
Q4 | $296M | Sell |
4,776,548
-50,362
| -1% | -$3.12M | 4.13% | 7 |
|
|
2020
Q3 | $265M | Hold |
4,826,910
| – | – | 4.84% | 3 |
|
|
2020
Q2 | $278M | Buy |
4,826,910
+650,000
| +16% | +$37.4M | 5.41% | 4 |
|
|
2020
Q1 | $168M | Buy |
4,176,910
+977,521
| +31% | +$39.3M | 5.3% | 3 |
|
|
2019
Q4 | $127M | Buy |
+3,199,389
| New | +$127M | 3.84% | 5 |
|
|
2013
Q4 | – | Sell |
-3,045,380
| Closed | -$16.9M | – | 35 |
|
|
2013
Q3 | $16.9M | Buy |
+3,045,380
| New | +$16.9M | 1.77% | 16 |
|